Mortality in patients with hematological malignancies, febrile neutropenia, and septic shock
The Journal of Infection in Developing Countries · 29.02.2024 · 18 (02) · 235-242
DOI: 10.3855/jidc.17451 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infection in Developing Countries, online erschienen am 29.02.2024. Verfasst von Beda Islas-Muñoz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Department, Instituto Nacional de Cancerología (INCan), Alcaldía Tlalpan, 14000 Mexico City. Hauptthemen laut MEDLINE: Shock, Septic, Hematologic Neoplasms, Neoplasms, Febrile Neutropenia. Die Arbeit wurde bisher 11-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Sepsis
Abstract (Originalsprache)
Introduction
Patients with severe neutropenia who develop septic shock (SS) have high mortality. This study aimed to evaluate the risk factors and mortality of SS in patients with HM and febrile neutropenia. Methodology: We included all patients with hematological malignancies (HM) who presented fever and severe neutropenia, admitted to an oncological tertiary care center in Mexico City for one year.
Results
Two hundred ninety-two episodes of fever and severe neutropenia were documented; 68 patients (23.2%) developed SS. Documented clinical infection was different between SS and non-SS patients (94.1% vs. 63.4%, p < 0.001); pneumonia was the most frequent infection (36.8% vs. 23.2%, p = 0.02). Also, in SS vs. non-SS, there were more positive cultures (69.1% vs. 38.4%, p < 0.001), higher frequency of Gram-negative bacteria (89.3% vs. 63.9%, p < 0.001), particularly Escherichia coli (68% vs. 44.2%) and Klebsiella spp. (23.4% vs. 15.1%). There were no differences when multidrug-resistant (MDR) microorganisms were compared. In the multivariate analysis, associated risk factors for SS were: prolonged neutropenia, a documented site of infection, and having received highly myelosuppressive chemotherapy. Risk factors for mortality at 30 days were: older patients, prolonged neutropenia, and SS.
Conclusions
Severe and prolonged neutropenia was associated with SS development and mortality at 30 days. ICU management should be offered to all critically ill patients with HM if long-term survival of the underlying malignancy is expected.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Infectious Diseases Department, Instituto Nacional de Cancerología (INCan), Alcaldía Tlalpan, 14000 Mexico City.
- Hematology Department, Instituto Nacional de Cancerología (INCan), Alcaldía Tlalpan, 14000 Mexico City, Mexico.
Zitieren
APA
Islas-Muñoz, B., Volkow-Fernández, P., Silva-Zamora, J., Ramírez-Ibarguen, A., & Cornejo-Juárez, P. (2024). Mortality in patients with hematological malignancies, febrile neutropenia, and septic shock. The Journal of Infection in Developing Countries, 18(02), 235-242. https://doi.org/10.3855/jidc.17451
Vancouver
Islas-Muñoz B, Volkow-Fernández P, Silva-Zamora J, Ramírez-Ibarguen A, Cornejo-Juárez P. Mortality in patients with hematological malignancies, febrile neutropenia, and septic shock. The Journal of Infection in Developing Countries. 2024;18(02):235-242. doi:10.3855/jidc.17451
BibTeX
@article{IslasMuoz2024,
author = {Islas-Muñoz, Beda and Volkow-Fernández, Patricia and Silva-Zamora, Jorge and Ramírez-Ibarguen, Ana and Cornejo-Juárez, Patricia},
title = {Mortality in patients with hematological malignancies, febrile neutropenia, and septic shock},
journal = {The Journal of Infection in Developing Countries},
year = {2024},
volume = {18},
number = {02},
pages = {235--242},
doi = {10.3855/jidc.17451}
}
EUVIMED